Phone: (919)-558-1323

Contact Us | Our Team
  • Modeling Liver Toxicity

    Using mechanistic modeling to solve liver toxicity problems

    DILIsym Services, Inc. utilizes the DILIsym® software to evaluate the Drug Induced Liver Injury (DILI) and hepatotoxic risk for compounds throughout the clinical development pipeline.

    Learn more

    “We look forward to future efforts to apply this model (DILIsym®) for prediction of hepatotoxicity that has not been clinically observed.” - Shon and Abernethy, 2014 Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, FDA

  • Predicting DILI

    Designed to be used during drug development, the DILIsym® modeling software provides an enhanced understanding of DILI hazards at various stages of development.

    Read more
  • DILI Biomarker Analysis

    DILIsym® has been used to quantify liver injury based on measured biomarkers to support interactions with regulatory agencies.

    Read more
  • Support Clinical Development Decisions

    Predictions made with DILIsym® are placed within the context of decisions facing pharma during clinical development.

    Read more

DILIsym Services, Inc. retains an association with the DILI-sim Initiative. More information can be found at